» Articles » PMID: 24889636

Metformin Promotes Lifespan Through Mitohormesis Via the Peroxiredoxin PRDX-2

Overview
Specialty Science
Date 2014 Jun 4
PMID 24889636
Citations 160
Authors
Affiliations
Soon will be listed here.
Abstract

The antiglycemic drug metformin, widely prescribed as first-line treatment of type II diabetes mellitus, has lifespan-extending properties. Precisely how this is achieved remains unclear. Via a quantitative proteomics approach using the model organism Caenorhabditis elegans, we gained molecular understanding of the physiological changes elicited by metformin exposure, including changes in branched-chain amino acid catabolism and cuticle maintenance. We show that metformin extends lifespan through the process of mitohormesis and propose a signaling cascade in which metformin-induced production of reactive oxygen species increases overall life expectancy. We further address an important issue in aging research, wherein so far, the key molecular link that translates the reactive oxygen species signal into a prolongevity cue remained elusive. We show that this beneficial signal of the mitohormetic pathway is propagated by the peroxiredoxin PRDX-2. Because of its evolutionary conservation, peroxiredoxin signaling might underlie a general principle of prolongevity signaling.

Citing Articles

NFAT5 exacerbates β-cell ferroptosis by suppressing the transcription of PRDX2 in obese type 2 diabetes mellitus.

Guan G, Liu J, Zhang Q, He M, Liu H, Chen K Cell Mol Life Sci. 2025; 82(1):64.

PMID: 39875646 PMC: 11775373. DOI: 10.1007/s00018-024-05563-y.


Mutations of the Electron Transport Chain Affect Lifespan and ROS Levels in .

osz F, Nazir A, Takacs-Vellai K, Farkas Z Antioxidants (Basel). 2025; 14(1).

PMID: 39857410 PMC: 11761250. DOI: 10.3390/antiox14010076.


Diet-Modifiable Redox Alterations in Ageing and Cancer.

Hine C, Patel A, Ponti A Subcell Biochem. 2024; 107():129-172.

PMID: 39693023 PMC: 11753504. DOI: 10.1007/978-3-031-66768-8_7.


Targeting immunosenescence for improved tumor immunotherapy.

Liu Z, Zuo L, Zhou Z, Liu S, Ba Y, Zuo A MedComm (2020). 2024; 5(11):e777.

PMID: 39473905 PMC: 11518697. DOI: 10.1002/mco2.777.


Therapeutic Effects of Metformin on Central Nervous System Diseases: A Focus on Protection of Neurovascular Unit.

Cai C, Gu C, Meng C, He S, Thashi L, Deji D Pharm Res. 2024; 41(10):1907-1920.

PMID: 39375240 DOI: 10.1007/s11095-024-03777-0.


References
1.
Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J . Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001; 108(8):1167-74. PMC: 209533. DOI: 10.1172/JCI13505. View

2.
Anisimov V, Berstein L, Egormin P, Piskunova T, Popovich I, Zabezhinski M . Metformin slows down aging and extends life span of female SHR mice. Cell Cycle. 2008; 7(17):2769-73. DOI: 10.4161/cc.7.17.6625. View

3.
Depuydt G, Xie F, Petyuk V, Shanmugam N, Smolders A, Dhondt I . Reduced insulin/insulin-like growth factor-1 signaling and dietary restriction inhibit translation but preserve muscle mass in Caenorhabditis elegans. Mol Cell Proteomics. 2013; 12(12):3624-39. PMC: 3861712. DOI: 10.1074/mcp.M113.027383. View

4.
Stachowicz A, Suski M, Olszanecki R, Madej J, Okon K, Korbut R . Proteomic analysis of liver mitochondria of apolipoprotein E knockout mice treated with metformin. J Proteomics. 2012; 77:167-75. DOI: 10.1016/j.jprot.2012.08.015. View

5.
Miller R, Buehner G, Chang Y, Harper J, Sigler R, Smith-Wheelock M . Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell. 2005; 4(3):119-25. PMC: 7159399. DOI: 10.1111/j.1474-9726.2005.00152.x. View